MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies _ Stroke
Penumbra Inc. (NYSE:PEN)-CCF*
Organization & Developments: Penumbra
Parents
Penumbra Inc. (NYSE:PEN)-CCF*
Children
*It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular.
*Penumbra, Inc. is a medical device company focused on the development of innovative, minimally invasive products for the prevent
*REAL Immersive System
*The medical technology company makes medical devices used to help patients experiencing a stroke or other vascular conditions.
2016: Penumbra: Impending Lockup Expiration And Short Opportunity - Penumbra (NYSE:PEN)
2019: Can This Medtech Reimagine Stroke Treatment — And Take On Big Rivals?_www.investors.com
2019: Why This IBD Stock Of The Day Broke Out Following A Five-Day Sprint_www.investors.com
2020: Penumbra: Unique Play For Virtual Reality Exposure In Medical Technology
2023: Penumbra Riding Higher On Upcoming Launches And Rerating_ seekingalpha.com
2023: Penumbra: Appeal Improves, Just Not Appealing Yet
2023: Penumbra: Consolidation Does Nothing To Change Long-Term Thesis, Reiterate Buy
2024: Decoding Penumbra Inc (PEN): A Strategic SWOT Insight
2024: Penumbra axes virtual reality division, will lay off 71 people
2024: Penumbra Grinding Through A Painful Growth Expectations Reset
2024: Penumbra Q4: Solid Is Not Good Enough
2024: Penumbra, Inc. (PEN): Innovating in Thrombectomy and Embolization with New FDA-Approved Technologies
2024: Penumbra: Appeal Improves As Operating Leverage Continues
2025: Penumbra Off And Running On Renewed Enthusiasm For Mechanical Thrombectomy
2025: Penumbra: Re-Rated For The Wrong Reasons
Jumps
*Key People: Penumbra
Finance & Acquisitions: Penumbra